MEAN TIME PARAMETERS REVEAL DIFFERENCES IN THE PHARMACOKINETICS OF IN-111 AND IODINE-131-LABELED B72.3 MONOCLONAL-ANTIBODY - REPLY

被引：0
|
作者：
WEBSTER, WB
HARWOOD, SJ
CARROLL, RG
MORRISEY, MA
机构：
来源：
JOURNAL OF NUCLEAR MEDICINE | 1992年 / 33卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：2249 / 2250
页数：2
相关论文
共 50 条
  • [21] COMPARTMENTAL ANALYSIS OF THE PHARMACOKINETICS OF RADIOIODINATED MONOCLONAL-ANTIBODY B72.3 IN COLON CANCER-PATIENTS
    REILLY, RM
    KIRSH, J
    GALLINGER, S
    THIESSEN, JJ
    DAMANI, M
    HAY, K
    POLIHRONIS, J
    SCHMOCKER, B
    ODZE, R
    HOULE, S
    STERN, H
    NUCLEAR MEDICINE AND BIOLOGY, 1993, 20 (01): : 57 - 64
  • [22] RADIOIMMUNODETECTION OF COLORECTAL-CANCER METASTASES WITH I-131-LABELED MONOCLONAL-ANTIBODY B72.3 - A PILOT-STUDY TO DETERMINE EFFICACY OF DETECTION AND PHARMACOKINETICS
    STERN, H
    REILLY, R
    GALLINGER, S
    KIRSH, J
    DEANGELIS, C
    PAPA, M
    HAY, K
    POLIHRONIS, J
    SCHMOKER, B
    CANCER INVESTIGATION, 1993, 11 (02) : 129 - 134
  • [23] Immunolymphoscintigraphy in breast cancer:: Evaluation using 131I-labeled monoclonal antibody B72.3
    Fig, LM
    Brown, RS
    von Moll, L
    Appelman, HD
    Stevens, R
    Harness, J
    August, D
    Sondak, VK
    Chang, AE
    Zasadny, KR
    Fisher, SJ
    Johnson, JW
    Wicha, MS
    Colcher, D
    Lichter, AS
    Wahl, RL
    NUCLEAR MEDICINE AND BIOLOGY, 1998, 25 (03) : 251 - 260
  • [24] ENDOBRONCHIAL ADMINISTRATION OF I-131 B72.3 MONOCLONAL-ANTIBODY IN PATIENTS WITH LUNG-CANCER
    DELVECCHIO, S
    MANSI, L
    PETRILLO, A
    CAMERA, L
    SOFIA, M
    MARRA, A
    CARRATU, L
    SALVATORE, M
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1991, 18 (02): : 129 - 132
  • [25] INTRABRONCHIAL ADMINISTRATION OF I-131 B72.3 MONOCLONAL-ANTIBODY IN PATIENTS WITH LUNG-CANCER
    DELVECCHIO, S
    MANSI, L
    GAGLIARDI, N
    PETRILLO, A
    SOFIA, M
    CARRATU, L
    SALVATORE, M
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1988, 14 (5-6): : 232 - 232
  • [26] A PROSPECTIVE-STUDY OF RECURRENCE IN COLON CANCER WITH I-131 B72.3 MONOCLONAL-ANTIBODY
    SALVATORE, M
    LASTORIA, S
    MANSI, L
    RENDA, A
    COLCHER, D
    SCHLOM, J
    LARSON, SM
    CALLEGARO, L
    JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (06) : 1023 - 1023
  • [27] Preparation of 105Rh labeled monoclonal antibody (MAb B72.3) using aminobenzylpropyleneamineoxime as the bifunctional chelating agent;: Comparison to 131I labeled MAb B72.3
    Venkatesh, M
    Schlemper, EO
    Jurisson, SS
    Ketring, AR
    Volkert, WA
    Corlija, M
    RADIOCHIMICA ACTA, 1999, 85 (3-4) : 157 - 163
  • [28] INTRAPERITONEAL INFUSION OF I-131-LABELED MURINE MONOCLONAL-ANTIBODY (B72.3) FOR RADIOIMAGING AND RADIOIMMUNOTHERAPY OF ADVANCED OVARIAN-CANCER
    KAPLAN, EH
    ZIMMER, AM
    LURAIN, J
    MILLER, DS
    KAZIKIEWICZ, JM
    GOLDMANLEIKIN, RE
    MANZEL, L
    SPIES, SM
    SPIES, WG
    RADOSEVICH, JA
    HIDVEGI, D
    ROSEN, ST
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 425 - 425
  • [29] PREVENTING RENAL UPTAKE OF IN-111 FROM LABELED MONOCLONAL-ANTIBODY FRAGMENTS - A REPLY
    HALPERN, SE
    KOZIOL, JA
    NUCLEAR MEDICINE COMMUNICATIONS, 1995, 16 (08) : 711 - 711
  • [30] TARGETING, DOSIMETRY, AND RADIOIMMUNOTHERAPY OF B-CELL LYMPHOMAS WITH IODINE-131-LABELED LL2 MONOCLONAL-ANTIBODY
    GOLDENBERG, DM
    HOROWITZ, JA
    SHARKEY, RM
    HALL, TC
    MURTHY, S
    GOLDENBERG, H
    LEE, RE
    STEIN, R
    SIEGEL, JA
    IZON, DO
    BURGER, K
    SWAYNE, LC
    BELISLE, E
    HANSEN, HJ
    PINSKY, CM
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (04) : 548 - 564
12345